Skip to main content
Daehan Nupharm Co.,Ltd. logo

Daehan Nupharm Co.,Ltd. — Investor Relations & Filings

Ticker · 054670 ISIN · KR7054670005 LEI · 988400PSHJB5UWD6MA19 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 184 across all filing types
Latest filing 2025-09-30 Major Shareholding Noti…
Country KR South Korea
Listing KO 054670

About Daehan Nupharm Co.,Ltd.

https://www.dhnp.co.kr

Daehan Nupharm Co., Ltd. is a pharmaceutical company that develops, manufactures, and markets a wide range of health products. Its business is structured around four key segments: human pharmaceuticals, providing effective and safe therapeutics; animal health, offering products for both livestock and companion animals; biopharmaceuticals, focusing on the development of next-generation treatments such as cell therapy; and health functional foods. The company prioritizes innovation and quality through its dedicated research and development centers, aiming to advance health outcomes with scientifically-backed solutions.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 90% confidence The document is a Korean "주식등의 대량보유상황보고서(일반)" (Large Shareholding Status Report) detailing the number of shares, percentages, special relationships, and changes in share ownership. It is a mandatory disclosure under the Capital Markets Act for significant shareholding levels. This matches the Major Shareholding Notification category.
2025-09-30 Korean
[기재정정]신규시설투자등
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Daehan New Pharm regarding a correction to a previous disclosure about a 'New Facility Investment'. It details changes to the investment completion date and provides updated figures for the capital expenditure. Since this is a specific regulatory announcement regarding corporate capital investment and facility expansion, and it does not fit into the other specific categories like M&A or share issues, it is classified as a general Regulatory Filing (RNS).
2025-08-28 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Daehan Nupharm Co., Ltd., covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which is characteristic of an interim/quarterly report. It is not an announcement of a report, but the report itself. H1 2025
2025-08-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the shareholding status, changes in ownership, and collateral agreements (pledges) of major shareholders and special related parties of '대한뉴팜(주)'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-08-07 Korean
[기재정정]신규시설투자등
Regulatory Filings Classification · 100% confidence The document is a regulatory filing regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to the investment amount and the completion date of a factory expansion project. Since this relates to capital expenditure and financing/investment activities rather than a report publication announcement or a general regulatory notice, it falls under the 'Capital/Financing Update' category.
2025-07-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (pledges) of major shareholders. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-05-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.